Transforming growth factor 131 null mice (TGF-131 -/-) suffer from multifocal inflammation and die by 3-4 wk of age. In these mice, levels of nitric oxide (NO) reaction products in serum are elevated approximately fourfold over levels in controls, peaking at 15-17 d of life. Shortterm treatment of TGF-131 -/-mice with NG-monomethyl-L-arginine suppressed this elevated production of NO. Expression of inducible NO synthase (iNOS) mR.NA and protein is increased in the kidney and heart ofTGF-131 -/-mice. These findings demonstrate that TGF-131 negatively regulates iNOS expression in vivo, as had been inferred from mechanistic studies on the control ofiNOS expression by TGF-131 in vitro.
T
he three mammalian isoforms of TGF-13 mediate a wide array of physiological processes (1) . In addition to their functions in development, cell cycle control, and wound healing, the TGF-13s regulate the function of cells involved in the immune response to antigens, mitogens, and pathogens (2) . Among the immunomodulatory effects attributed to the TGF-13s is the suppression of the production of nitrogen free radicals by macrophages in vitro (3) . Nitric oxide (NO) and its derived nitrogen free radicals have been the subject of much investigation, owing to their pleiotropic effects (4) . An enzyme inducible by cytokines and microbial products present in many cell types (iNOS; NOS type II) produces large quantities of NO (4) . The cytotoxic or cytostatic effects of high levels of NO are beneficial during infection but can damage host tissue when unchecked (4) . Accordingly, suppression of NO production by exogenously administered TGF-131 can have both deleterious and beneficial effects in different contexts (5) .
To discern whether endogenous TGF-131 can control the expression of iNOS in vivo, we made use of the TGF-131 null (TGF-131 -/-) mouse (6) . In contrast with normal (TGF-131 +/+) or heterozygous (TGF-131 +/-) litterrnates, these mice develop multifocal inflammation and die after a wasting syndrome (6) . TGF-131-/-mice exhibit high levels of circulating autoantibodies (7) as well as increased expression of MHC class I and II in the absence of increased expression of IFN-~/ (8), suggesting that TGF-131 may be an active repressor of inflammation even in the absence of proinflammatory stimuli. For these reasons, and owing to the multiple regulatory effects of TGF-131 on NO production in vitro (5), we examined whether production of NO is dysregulated in TGF-131 -/-mice.
Materials and Methods
TGF-~I-/-Mice. TGF-131 -/-mice were derived as described previously (6) and maintained in a specific pathogen-free animal room. By routine screening of the animal colony, the mice were determined not to be infected with any identifiable pathogens 1 (data not shown). TGF-131-/-mice were identified by expressing the null allele and not the normal allele. Genotyping was performed by PCR. from tail preparations as described previously (8, 9) .
Treatment Protocols. Mice were injected intraperitoneally with Ng-monomethyl-L-arginine (L-NMA; 50-400 mg/kg; Sigma Chemical Co., St. Louis, MO), NG-nitro-L-arginine methyl ester (r-NAME; 50 mg/kg; Sigma), or aminoguanidine (50 mg/kg; Sigma). All injected solutions were diluted in sterile PBS and sterile filtered before injection.
Preparation of Serum. Mice were killed by asphyxiation in CO 2, and blood was collected in microcentrifuge tubes after cardiac puncture. Serum was obtained after centrifugation of coagulated blood and stored at -70~
Quantitation of N02 and NO~ in Serum. Serum NO ~-and NO 3 were assayed by reduction of NO2 to NO~ on Cd filings as described elsewhere (10) . The samples were then assayed for NO2 1Mice were screened routinely for the following pathogens: murine hepatitis virus, pneumonia virus of mice, polioencephalomyelitis virus, lymphocytic choriomeningitis virus, mouse cytomegalovirus, reovirus type 3, ectromelia virus, and mouse polyoma virus, as well as several types ofparovirus, ectoparasites, and endoparasites.
content by the Griess assay as described elsewhere (3, 11) . The NO2 + NO~ content of selected serum samples was verified by a modification of the nitrate reductase method (12 purified by the CsC1 method as described previously (8, 9) . 15 ~g of total RNA was electrophoresed and blotted by standard methods (13) . Northern blotting was carried out according to the procedure of Church and Gilbert (14) with the HinclI-EcoiLI fragment of the iNOS cDNA (15) and the 675-bp region within the TGF-[31 precursor cDNA starting at the ATG initiation codon (16) . After hybridization, the filters were exposed to a PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA).
Anti-iNOS Antibodies. For immunocytochemical detection of
iNOS, we used a rabbit polyclonal antiserum raised against the carboxy terminal EEPKATILL peptide of mouse iNOS coupled to thyroglobulin as a Carrier by use of sulfo-MBS chemistry (Pierce Chem. Co., ILockford, IL) (17) . For irnmunoblotting, we used a mouse mAb raised against a fragment of mouse iNOS from amino acids 961-1144 (Transduction Laboratories, Lexington, KY).
SDS-PAGE and Immunobtotting.
150--250 I~g of each homogenate was separated on precast 4-20% polyacrylamide gels (NOVEX, Encinitas, CA) along with prestained mol wt standards (Amersham Corp., Arlington Heights, IL). As a positive control for mouse iNOS, RAW 264.7 cells (American Type Culture Collection, ILockville, MD) were stimulated with IFN-~/(100 U/ml; GIBCO BILL, Gaithersburg, MD) and LPS (200 ng/ml; prepared by phenol extraction from Escherichia coli Ol1:5; List Biological Laboratories, Inc., Campbell, CA) as described elsewhere (18) . The separated proteins were immunoblotted by standard methods. In brief, membranes were blocked with 5% nonfat dry milk and incubated with a 1 : 5,000 dilution in 5% nonfat dry milk of anti-iNOS. Secondary antibody was a goat anti-mouse IgG coupled to HILP (Kirkegaard and Perry Laboratories, Gaithersburg, MD). The membranes were visualized by enhanced chemiluminescence (Amersham).
Histopathology and Immunohistochemistry. Tissues were fixed in 10% buffered formalin and embedded in paraffin. 5-lxm sections were stained with hematoxylin-eosin and analyzed for histopathology. Tissue sections were deparaffinized at 65~ followed by incubation in xylene and ethanol. After endogenous peroxidase activity was blocked in HzO2-methanol, and nonspecific binding in 5% BSA, 1% normal goat serum was carried out, sections were incubated overnight at 4~ with anti-iNOS at a dilution of 1 : 1,000. Control for specificity of iNOS was normal rabbit serum. The adherent antibodies were reacted with biotinylated goat anti-rabbit or horse anti-mouse secondary antibodies followed by HILP conjugated to streptavidin (Vector Laboratories, Burlingame, CA). These complexes were visualized with 3,Y-diaminobenzidine (Sigma) as a chromagen and CuSO 4 as an enhancer. Sections were then counterstained with Meyers hematoxylin and coverslipped. The stained sections were imaged digitally.
Data Analysis. Data are presented as mean + SEM unless stated otherwise and were analyzed for significance by the unpaired one-tailed Student's t-test.
Results and Discussion
The experiments described herein were carried out on TGF-131 -/-mice obtained sequentially, owing to the low frequency of TGF-I31 -/-mice in most litters (6, 19) . We first looked for evidence of increased systemic production of NO, by assaying for NO2 and NO3, the predominant reaction products of NO found in serum (4). We also divided TGF-[31 +/+ and TGF-131 -/-mice into cohorts of equal age between 10 and 28 d to relate the age of the mice to serum NO~ and NO3 content as an indicator of systemic NO production. Serum levels of NO~ and NO3 of TGF-{31 -/-mice were generally higher than those of (Fig. 1) . This spontaneously elevated systemic N O production is quite substantial: although all mice were free from infection (data not shown), the serum levels of N O~ and N O 3 observed in TGF-[31-/-mice are comparable to those of mice injected with C. parvum (20) or staphylococcal enterotoxin B (21) . The increase in systemic N O production in TGF-[31 -/ -mice is greatest approximately at the time o f weaning (Fig. 1) , suggesting an association with decreased maternally transferred TGF-[31 (9) .
Systemic N O production in TGF-[31+/+ mice was relatively constant over 10-28 d of age, though some fluctuation was observed (Fig. 1, open squares (11, 22, 23) , it is only one of a multitude of agents that suppress the expression o f iNOS in vitro: the cytokines TGF-[32, TGF-[33, platelet-derived growth factor, fibroblast growth factor, epidermal growth factor, insulin-like growth factor, and interleukins 4, 8, and 10 (5); endogenous corticosteroids (24) ; N,N-dimethylarginine (25) ; thrombin (26) ; angiotensin II (27) ; and osteopontin (28) . It is unknown whether the absence of TGF-[31 leads to increased expression of any or all of these agents.
The observation that systemic N O production is dramatically increased in TGF-[31-/-mice suggested that this increase was in some way related to the wasting syndrome and death characteristic o f these mice (6, 19) . W e therefore determined whether suppression o f N O S enzyme activity would contribute to or correlate with an increase in the life span o f these mice. W e compared the serum levels of N O 2 and N O 3 o f untreated TGF-[31 -/ -mice 14--17 d o f age with those o f mice that had been either untreated or treated for ~-,1 wk with t -N M A (Fig. 2) , t -N A M E (data not shown), or aminoguanidine (data not shown). As can be seen in Fig. 2, 14-- The expression ofiNOS mRNA and protein is higher in the heart and kidneys ofTGF-I31 -/-mice relative to TGF-I$1 § littermates. Mice were sacrificed at the indicated ages, and the hearts (A and B) and kidneys (C and D) removed. The organs were processed for Northern blot analysis with a probe specific to iNOS or GAPDH as a control for loading (A and C) or immunoblot with anti-iNOS antibody (B and D). Migration of iNOS produced by the mouse macrophage-like cell line RAW264.7 (data not shown) is indicated by the arrow. Experiment is representative of three. P <0.001 or t-NAME or aminoguanidine (data not shown), all competitive inhibitors of NOS activity (4), demonstrating that the increased levels of NO2 and NO3 were due to aberrantly high NOS activity and not to another metabolic aberration. Treatment with these agents did not result in increased life span of TGF-[31 -/ -mice, but long-term treatment with a glucocorticoid or rapamycin resulted in suppression of systemic N O production and was associated with increased hfe span of TGF-[31 -/ -mice (Letterio, J.J., Y. Vodovotz, A.G. Geiser, L. Chesler, A. Campbell, and A.B. Roberts, manuscript in preparation).
Our analysis of the age dependence of systemic N O production suggested that either iNOS expression or its activity may be reduced by some mechanism in the days before the death of TGF-131 -/ -mice. Homogenates from mice 14-21 d of age showed that iNOS mRNA and protein were expressed at their highest levels in the heart (Fig. 3, A and B, respectively) and kidney (Fig. 3, C and D, respectively) between days 15 and 17 in the life of TGF-[31 -/ -mice, in parallel with serum NO2 and NO3 levels ( Fig. 1) . At later time points, however, iNOS protein expression in the heart and kidney ofTGF-[31 -/ -mice decreased to levels almost indistinguishable from those of TGF-[31 +/+ httermates (data not shown). We next characterized the expression of iNOS protein at the cellular level by immunocytochemistry, iNOS protein was expressed at low levels in the medulla of TGF-[31+/+ mice (data not shown). We did not find significant expression of iNOS in glomeruli of TGFq31 +/+ mice (Fig. 4 A) . We found that the expression of iNOS protein was increased in the collecting ducts and tubular epithelial cells, but not the glomeruli, of TGF-131 -/-mice relative to its expression in controls (Fig. 4; compare A and B) .
The increased expression of iNOS mP,.NA (Fig. 3 C) and protein ( Fig. 3 D and Fig. 4 ) in the kidney, an organ that is typically not inflamed in TGF-[M -/ -mice (6, 19) , suggests that the increase in iNOS expression may not solely be due to the inflammatory infiltrate observed in TGF-131 -/ -mice. Two mouse models of autoimmunity, that of experimental autoimmune encephalomyelitis (29) and that of the MRL-Ipr/lpr mouse (30) , are also associated with in- The role of N O in this system was to suppress the proliferation of T lymphocytes: inhibition of N O production in mice undergoing shock increased morbidity owing to increased T lymphocyte proliferation and subsequent production of TNF-ot (21) .
The increase in iNOS expression in TGF-131 -/ -mice is most probably mediated indirectly via increases in the expression of proinflammatory cytokines. Cytokines such as IFN-y, TNF-ot, IL-1, or IL-2 may induce iNOS (4) and are known to be regulated by TGF-131 (2). Shull et al. (19) have reported that TGF-[31 -/ -mice exhibit increased expression of TNF-ot and IFN-~/ mlkNA, but not IL-lix mP, NA, as determined by PCP, analysis of liver and lung tissues. Christ et al. (33) have reported elevated IL-2 levels in the thymus of TGF-IM -/ -mice. However, a previous study from our laboratory suggested that the expression of IFN-~/ mRNA was not altered in TGF-[31 -/ -mice relative to its expression in controls (8) . Future studies must determine the cellular and organ source of the increased circulating levels of metabolites of NO, identify the mechanisms which shut off N O production late in the life of TGF-131 -/ -mice, and the direct physiological consequences the increased production of NO has on TGF-131-/-mice. 
